The content is available as a PDF (227.3 KB).
letter . 2020 Apr 23:dgaa225. doi: 10.1210/clinem/dgaa225
Letter to Editor Response to Covid-19 Endocrinology & Diabetology
Karl Z Nadolsky
✉
Karl Z Nadolsky, DO
Find articles by Karl Z Nadolsky
✉
Corresponding author: Karl Z Nadolsky, DO, Assistant Clinical Professor, Michigan State University College of Human Medicine, Contact: Karl Nadolsky, Address: 221 Michigan Ave, Grand Rapids, MI 49503, Phone: 616-886-6205, Fax: 616-267-8585, Email: Karl.nadolsky@spectrumhealth.org
Received 2020 Apr 10.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7188111 PMID: 32322893